These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
925 related articles for article (PubMed ID: 16033477)
1. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma]. Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477 [TBL] [Abstract][Full Text] [Related]
3. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123 [TBL] [Abstract][Full Text] [Related]
4. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
5. Current melanoma staging. Petro A; Schwartz J; Johnson T Clin Dermatol; 2004; 22(3):223-7. PubMed ID: 15262308 [TBL] [Abstract][Full Text] [Related]
6. [The new TNM classification of malignant melanoma]. Oláh J; Dobozy A Magy Onkol; 2003; 47(1):59-61. PubMed ID: 12704456 [TBL] [Abstract][Full Text] [Related]
7. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Balch CM; Buzaid AC; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Houghton A; Kirkwood JM; Mihm MF; Morton DL; Reintgen D; Ross MI; Sober A; Soong SJ; Thompson JA; Thompson JF; Gershenwald JE; McMasters KM Cancer; 2000 Mar; 88(6):1484-91. PubMed ID: 10717634 [TBL] [Abstract][Full Text] [Related]
8. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma. Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885 [TBL] [Abstract][Full Text] [Related]
9. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry. Eigentler TK; Buettner PG; Leiter U; Garbe C; J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379 [TBL] [Abstract][Full Text] [Related]
10. The natural course of cutaneous melanoma. Leiter U; Meier F; Schittek B; Garbe C J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. Leiter U; Buettner PG; Eigentler TK; Garbe C J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905 [TBL] [Abstract][Full Text] [Related]
12. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma. Retsas S; Mastrangelo MJ Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372 [TBL] [Abstract][Full Text] [Related]
13. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346 [TBL] [Abstract][Full Text] [Related]
14. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related]
15. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
16. [Primary cutaneous melanoma: prognostic factors not included in the classification of the American Joint Committee on Cancer]. Tejera-Vaquerizo A; Solís-García E; Ríos-Martín JJ; Moreno-Ramírez D Actas Dermosifiliogr; 2011 May; 102(4):255-63. PubMed ID: 21440241 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434 [TBL] [Abstract][Full Text] [Related]
18. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging. Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252 [TBL] [Abstract][Full Text] [Related]
19. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. Doeden K; Ma Z; Narasimhan B; Swetter SM; Detmar M; Dadras SS J Cutan Pathol; 2009 Jul; 36(7):772-80. PubMed ID: 19032379 [TBL] [Abstract][Full Text] [Related]
20. [Prognosis of malignant melanoma following dissection regional lymph node metastases]. Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]